Reference Source

Shanghai No. 1 Biochemical & Pharmaceutical Co., Ltd. · 66-40 · CHINA

For Shanghai No. 1 Biochemical & Pharmaceutical Co., Ltd. · 66-40 · CHINA, import alert is 66-40; import alert name is "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"; country is CHINA; product code is 55 R - - 75 Crude Heparin (Pharmaceutic Necessity) | 55 R - - 99 Pharmaceutic Necessities, N.E.C. | 57 D - - 38 Whole Blood (Human) Heparin (Blood and Blood Derivatives) | 61 L - - 08 Heparin Sodium (Anti-Coagulant) | 61 L - - 22 Anti-Coagulant Heparin Sol | 61 L - - 30 Heparin Calcium (Anti-Coagulant) | 80 N - - ZW Heparin Vascular access flush | 81 J - - BR Test, Heparin Neutralization | 81 J - - OX Analyzer, Heparin, Automated | 81 K - - FF Assay, Heparin; date published is 09/10/2009; address is 387 Shangqiulu , Shanghai, Shanghai CHINA, verified against its source on 2026-09-16.

Firm
Shanghai No. 1 Biochemical & Pharmaceutical Co., Ltd. verified
Import alert
66-40
Import alert name
"Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"
Country
CHINA verified
Address
387 Shangqiulu , Shanghai, Shanghai CHINA verified
Date published
09/10/2009 verified
Product code
55 R - - 75 Crude Heparin (Pharmaceutic Necessity) | 55 R - - 99 Pharmaceutic Necessities, N.E.C. | 57 D - - 38 Whole Blood (Human) Heparin (Blood and Blood Derivatives) | 61 L - - 08 Heparin Sodium (Anti-Coagulant) | 61 L - - 22 Anti-Coagulant Heparin Sol | 61 L - - 30 Heparin Calcium (Anti-Coagulant) | 80 N - - ZW Heparin Vascular access flush | 81 J - - BR Test, Heparin Neutralization | 81 J - - OX Analyzer, Heparin, Automated | 81 K - - FF Assay, Heparin each item verified
FDA notes
All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 | All Heparin Products 1/21/2009 each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Shanghai No. 1 Biochemical & Pharmaceutical Co., Ltd. Date Published : 09/10/2009 387 Shangqiulu , Shanghai, Shanghai CHINA 55 R - - 75 Crude Heparin (Pharmaceutic Necessity) Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 55 R - - 99 Pharmaceutic Necessities, N.E.C. Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 57 D - - 38 Whole Blood (Human) Heparin (Blood and Blood Derivatives) Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 61 L - - 08 Heparin Sodium (Anti-Coagulant) Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 61 L - - 22 Anti-Coagulant Heparin Sol Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 61 L - - 30 Heparin Calcium (Anti-Coagulant) Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 80 N - - ZW Heparin Vascular access flush Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 81 J - - BR Test, Heparin Neutralization Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 81 J - - OX Analyzer, Heparin, Automated Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009 81 K - - FF Assay, Heparin Date Published: 09/10/2009 Notes: All Heparin Products 1/21/2009

accessdata.fda.gov, retrieved 2026-09-15

The same source also states

Shanghai No. 1 Biochemical & Pharmaceutical Co., Ltd. Date Published : 09/10/2009 1317 Jianchuanlu , Minhang District , Shanghai, Shanghai CHINA 55 - - - -- Pharm Necess & Ctnr For Drug/Bio Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only. 56 - - - -- Antibiotics (Human/Animal) Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only. 58 - - - -- Human and Animal Therapeutic Biologic and Biosimilar Drugs Date Published: 05/26/2022 60 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only. 61 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only. 62 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only. 63 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only. 64 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only. 65 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only. 66 - - - -- Human and Animal Drugs Date Published: 09/10/2009 Notes: All API's 1/21/2009 (original) 4/14/2009 (updated) Note: Other Shanghai No. 1 locations remain subject to DWPE for heparin products only.

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.